MahrukhMusharrafHussainMD

Oncology • Gaithersburg, MD

Physician

Join to view full profile

Dr. Hussain is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Hussain's full profile

Already have an account?

Office
655 Watkins Mill Rd
Gaithersburg, MD 20879
Phone+1 703-359-7460

Fax+1 240-632-4826
Is this information wrong?

Education & Training

National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1999 - 2002
Boston University Medical CenterResidency, Internal Medicine, 1996 - 1999
University of Maryland School of MedicineClass of 1996

Certifications & Licensure

VA State Medical License 2003 - 2024
MD State Medical License 2003 - 2024
DC State Medical License 2003 - 2024
WA State Medical License 2007 - 2008
MA State Medical License 1998 - 2005
American Board of Internal Medicine Medical Oncology

Clinical Trials

Carboxyamidotriazole in Treating Patients With Refractory or Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer Start of enrollment: 1998 Apr 01
Completed
Phase 2

Publications & Presentations

PubMed

Cabozantinib (XL184) in metastatic castration-resistant prostate cancer (mCRPC): Results from a phase II randomized discontinuation trial.
Hussain M, Smith MR, Sweeney C, Corn PG, Elfiky A, Gordon MS, Haas NB, Harzstark AL, Kurzrock R, Lara P, Lin C, Sella A, Small EJ, Spira AI, Vaishampayan UN, Vogelzang...> ;J. Clin. Oncol.. 2011-05-20
Targeting cancer stem cell-like phenotype in bladder cancer (BC) cell lines.
Grivas P, Liebert M, Kunju P, Day K, Day M, Hussain M> ;J. Clin. Oncol.. 2011-05-20
A phase II trial of neoadjuvant ABI-007, carboplatin, and gemcitabine (ACG) in patients with locally advanced carcinoma of the bladder.
Smith DC, Grivas P, Daignault S, Hafez K, Wood DP, Lee CT, Montie JE, Weizer AZ, Montgomery J, Hussain M> ;J. Clin. Oncol.. 2011-03-01
Phase II study of AT-101 to abrogate Bcl-2-mediated resistance to androgen-deprivation therapy (ADT) in patients (pts) with newly diagnosed androgen-dependent metastat...
Stein MN, Khan I, Hussain M, Liu G, Wilding G, Posadas EM, Stadler WM, Jeyamohan C, Eddy S, DiPaola RS> ;J. Clin. Oncol.. 2011-03-01
A randomized phase II study of pazopanib in castrate-sensitive prostate cancer: A University of Chicago phase II consortium/DoD Prostate Cancer Clinical Trials Consort...
Ward JE, Limvorasak S, Karrison T, Chatta GS, Hussain M, Shevrin DH, Szmulewitz RZ, Stadler WM, Posadas EM> ;J. Clin. Oncol.. 2011-03-01
20 citations
Ten-year follow-up of a phase 2 study of dose-intense paclitaxel with cisplatin and cyclophosphamide as initial therapy for poor-prognosis, advanced-stage epithelial o...
Gisele Sarosy, Mahrukh M. Hussain, Michael V. Seiden, Arlan F. Fuller, Najmosama Nikrui, Annekathryn Goodman, Lori M. Minasian, Eddie Reed, Seth M. Steinberg, Elise C....> ;Cancer. 2010 Mar 15
Maintenance sunitinib postchemotherapy (CT) in patients (pts) with advanced urothelial carcinoma (UC): A randomized placebo controlled phase II trial.
Bradley D, Daignault S, Smith DC, Nanus D, Tagawa S, Stadler WM, Garcia J, Dreicer R, Al-Hawary M, Hussain M> ;J. Clin. Oncol.. 2009-05-20
Prostate cancer clinical trials consortium: A multicenter mechanism for the rapid design, development, and implementation of early phase clinical trials.
Vinson J, Mathew P, Beer TM, Carducci MA, Oh W, Small E, Wilding G, Higano C, Hussain M, Scher HI> ;J. Clin. Oncol.. 2009-05-20
Expression and activation of ADAM15 in bladder cancer.
Bucheit A, Day K, Day ML, Chadwick WA, Liebert M, Hussain M> ;J. Clin. Oncol.. 2009-05-20
Phase I study of vorinostat plus docetaxel in patients with solid tumor malignancies.
Schneider BJ, Bradley D, Smith DC, Egorin M, Kalemkerian G, Dunn R, Daignault S, Hussain M> ;J. Clin. Oncol.. 2009-05-20
Non-Hodgkin's lymphoma of the thyroid-A review of 16 cases.
Soman LV, Narayanan G, Hussain M, Madhavan J> ;J. Clin. Oncol.. 2008-05-20
49 citations
A prospective analysis of imatinib-induced c-KIT modulation in ovarian cancer: a phase II clinical study with proteomic profiling.
Edwin M. Posadas, Virginia Kwitkowski, Herbert L. Kotz, Virginia Espina, Lori M. Minasian, Nana Tchabo, Ahalya Premkumar, Mahrukh M. Hussain, Richard Chang, Seth M. St...> ;Cancer. 2007 Jul 15
101 citations
A phase II and pharmacodynamic study of gefitinib in patients with refractory or recurrent epithelial ovarian cancer.
Edwin M. Posadas, Meghan S. Liel, Virginia Kwitkowski, Lori M. Minasian, Andrew K. Godwin, Mahrukh M. Hussain, Virginia Espina, Bradford J. Wood, Seth M. Steinberg, El...> ;Cancer. 2007 Apr 1
Clinical outcome of taxane-resistant (TR) hormone refractory prostate cancer (HRPC) patients (pts) treated with subsequent chemotherapy (ixabepilone (Ix) or mitoxantro...
Lin AM, Rosenberg JE, Weinberg VK, Kelly WK, Michaelson MD, Hussain M, Wilding G, Gross ME, Small EJ> ;J. Clin. Oncol.. 2006-06-20
Absolute PSA value after androgen deprivation (AD) is a strong independent predictor of survival in new metastatic (D2) prostate cancer (PCa): Data from Southwest Onco...
Hussain M, Tangen CM, Schellhammer PF, Crawford ED, Higano CS, Wilding G, Akdas A, Small EJ, Donnelly B, Raghavan D> ;J. Clin. Oncol.. 2006-06-20
A randomized phase 2 study of the thrombospondin-mimetic peptide ABT-510 in patients with previously untreated advanced renal cell carcinoma.
Ebbinghaus SW, Hussain M, Tannir NM, Gordon MS, Desai AA, Knight RA, Carlson DM, Figlin RA> ;J. Clin. Oncol.. 2005-06-01
Trastuzumab (T), paclitaxel (P), carboplatin (C), and gemcitabine (G) in advanced HER2-positive urothelial carcinoma: Results of a multi-center phase II NCI trial.
Hussain M, Petrylak D, Dunn R, Vaishampayan U, Lara PN, Chatta G, Nanus D, Glode LM, Trump D, Chen H, Smith DC> ;J. Clin. Oncol.. 2005-06-01
A randomized phase II study of ixabepilone (Ix) or mitoxantrone and prednisone (MP) in patients with taxane (T)-resistant hormone refractory prostate cancer (HRPC).
Rosenberg JE, Kelly WK, Michaelson MD, Wilding G, Hussain M, Gross M, Small EJ> ;J. Clin. Oncol.. 2005-06-01
Nasopharyngeal carcinoma (NPC) in the Kingdom of Saudi Arabia. The experience of Princess Nourah Oncology Center (POC), Jeddah.
Alqadah FD, Alsafadi N, Shukla V, Andejani A, Hussain M, Malaker K, Darwish T, Qureishi K, Vijayananda K, Eid H> ;J. Clin. Oncol.. 2005-06-01
Neoadjuvant docetaxel and capecitabine in patients with high risk/locally advanced prostate cancer: Preliminary results of a phase II study.
Friedman JD, Vaishampayan U, Montie J, Shah R, Sarkar F, Smith D, Hussain M> ;J. Clin. Oncol.. 2005-06-01
Phase II study of interferon and thalidomide in metastatic renal cell carcinoma.
Tripathi RR, Patel B, Heilbrun L, Hussain M, Flaherty L, Vaishampayan UN> ;J. Clin. Oncol.. 2004-07-15
A phase II clinical trial with proteomic profiling of imatinib mesylate in patients with refractory or relapsed epithelial ovarian cancer (EOC).
Posadas EM, Hussain MM, Espina V, Kotz H, Minasian L, Shreeve SM, Premkumar A, Liotta LA, Steinberg SM, Kohn EC> ;J. Clin. Oncol.. 2004-07-15
A phase II evaluation of a 3-hour infusion of paclitaxel (P), cisplatin (CDDP) & 5-fluorouracil (5FU) in patients with advanced or recurrent squamous cell carcinoma of...
Worden FP, Moon J, Samlowski W, Clark J, Dakhil SR, Taylor SA, Urba SG, Hussain M> ;J. Clin. Oncol.. 2004-07-15
63 citations
Phase II Trial of Carboxyamidotriazole in Patients With Relapsed Epithelial Ovarian Cancer
Mahrukh M. Hussain, Herbert L. Kotz, Lori M. Minasian, Ahalya Premkumar, Gisele Sarosy, Eddie Reed, Suoping Zhai, Seth M. Steinberg, Miranda Raggio, Vyta Kulpa Oliver,...> ;Journal of Clinical Oncology. 2003 Dec 1
14 citations
Angiogenesis and metastasis.
Gregory J. Sieczkiewicz, Mahrukh M. Hussain, Elise C. Kohn> ;Cancer Treatment and Research. 2002 Jan 1
Join now to see all

Hospital Affiliations

Holy Cross HospitalSilver Spring, Maryland
MedStar Washington Hospital CenterWashington, District of Columbia

MahrukhMusharrafHussainMD

Dr. Hussain is on Doximity

Education & Training

Certifications & Licensure

Clinical Trials

Publications & Presentations

Hospital Affiliations

Viewing the full profile is available to verified healthcare professionals only.